Curebase
PrivateLast Round
Series B
May 5, 2022
Est. Valuation
$1.71M
Total Funding Raised
$58.97M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Curebase operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Series B round in May 2022.
Curebase is a healthcare technology company that provides an AI-powered eClinical software platform for decentralized clinical trials, streamlining participant eligibility, enrollment, education, and consent processes.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Vertical SaaS, Patient Engagement, Compliance
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Freemium
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Curebase Comparables
Compare Curebase with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| THREAD | 89% | |
| Obvio Health | 89% | |
| Vial | 86% |
For institutional investors. Book with your work email.
Curebase Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 5, 2022 | ||||
| Series A | May 25, 2021 | ||||
| Seed | Oct 1, 2018 | ||||
| Accelerator | Aug 22, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Curebase Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| World Innovation Lab | Series B |
| Gaingels | Series B |
| Positive Sum | Series B |
| Acrew Capital | Series B |
| FJ Labs | Seed |
| BOLD Capital Partners | Series A, Series B |
| Y Combinator | Accelerator |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 46% MoM, reaching 6.9K.
- May 5, 2022
$40M round led by Industry Ventures.
For institutional investors. Book with your work email.
Curebase Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Curebase's valuation, stock price, and market status.
Is Curebase a public or private company?
Curebase is a private company.
What is the current stock price of Curebase?
Curebase is a private company, so its shares have no public market price. Caplight tracks Curebase's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Curebase worth (valuation)?
Curebase's valuation is estimated at $1.7M based on funding round data.
Can I buy Curebase stock?
Curebase shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Curebase's last funding round?
Curebase's most recent funding round was Series B on May 5, 2022.
Who are the main investors in Curebase?
Key investors in Curebase include GGV Capital, Industry Ventures.
Will Curebase IPO soon?
No public IPO plans have been announced for Curebase.
How can I track Curebase secondary market activity?
Caplight tracks bids, offers, and trades in Curebase's shares on secondary markets.